Acute Viral Hepatitis: Clinical Presentation and Management
In a middle-aged adult presenting with fatigue, anorexia, nausea, right upper quadrant discomfort, dark urine, pale stools, and jaundice, acute viral hepatitis is the most likely diagnosis, requiring immediate serological testing to differentiate between hepatitis A, B, C, and E, with management focused on supportive care while monitoring for progression to acute liver failure.
Chief Complaint
The patient typically presents with:
- Jaundice (yellowing of skin and eyes)
- Dark urine (tea-colored)
- Fatigue and malaise
- Right upper quadrant discomfort or dull pain
History of Present Illness (HPI)
Prodromal Phase (1-2 weeks before jaundice)
- Flu-like symptoms: fever, fatigue, myalgias
- Gastrointestinal symptoms: anorexia (often prominent), nausea, vomiting, multiple loose stools 1
- Constitutional symptoms: malaise, headache
- Duration: typically days to 1-2 weeks
Icteric Phase
- Dark urine appearing 1-5 days before jaundice 1
- Jaundice of skin and sclera
- Pale/clay-colored stools
- Paradoxical improvement of systemic symptoms once jaundice appears 2
- Right upper quadrant discomfort or dull ache 3
Timeline
- Incubation period: 2-7 weeks for hepatitis A (mean 7 weeks) 4
- Symptom duration: typically 2-12 weeks 4
Review of Systems
Pertinent Positives to Elicit
- Constitutional: fever (may persist for days), night sweats, weight loss
- Gastrointestinal: anorexia (nearly universal), nausea, vomiting, diarrhea, abdominal pain
- Genitourinary: dark urine, decreased urine output
- Musculoskeletal: arthralgias (30-60% in autoimmune hepatitis, less common in viral) 5
- Dermatologic: pruritus, jaundice, rash (rare)
- Neurologic: confusion or altered mental status (critical red flag for acute liver failure)
Pertinent Negatives to Document
- No encephalopathy (confusion, altered consciousness, asterixis)
- No bleeding (gums, bruising, melena)
- No ascites or edema
Critical Red Flags
- Encephalopathy (any grade) - indicates progression to acute liver failure requiring urgent transplant evaluation 6
- Coagulopathy (easy bruising, bleeding)
- Severe nausea/vomiting preventing oral intake
Physical Examination
General Appearance
- Jaundice of skin and sclera (most frequent finding) 1
- Appears fatigued or acutely ill
- Assess mental status carefully for any confusion or drowsiness
Vital Signs
- Fever: may be present (low-grade typically)
- Tachycardia if dehydrated
- Hypotension (concerning for severe disease)
Abdominal Examination
- Hepatomegaly (most frequent physical finding) 1
- Liver edge palpable 2-6 cm below costal margin
- Tender to palpation
- Right upper quadrant tenderness
- Splenomegaly (less common, suggests chronic disease or EBV)
- Assess for ascites (shifting dullness, fluid wave) - suggests cirrhosis or severe acute disease
Skin Examination
- Jaundice severity
- Spider angiomata, palmar erythema (suggests chronic liver disease)
- Excoriations from pruritus
- Maculopapular rash (rare) 5
Neurological Examination
- Mental status: alert and oriented vs. confused
- Asterixis (flapping tremor) - indicates hepatic encephalopathy
- Grade encephalopathy if present (Grade 1-4)
Signs of Chronic Liver Disease (Suggests Pre-existing Cirrhosis)
- Ascites
- Peripheral edema
- Muscle wasting
- Gynecomastia
- Testicular atrophy
Provisional Diagnosis
Acute viral hepatitis (specific etiology to be determined by serology)
The clinical syndrome of acute hepatitis with jaundice, elevated transaminases, and constitutional symptoms is consistent with viral hepatitis. The specific virus (A, B, C, E) cannot be determined clinically and requires serological confirmation 7.
Differential Diagnosis
Must Exclude Immediately
Drug-induced liver injury (DILI)
Autoimmune hepatitis (AIH)
Acute liver failure causes
- Wilson's disease (especially if age <40 years)
- Ischemic hepatitis (shock liver)
- Budd-Chiari syndrome (hepatic vein thrombosis)
- Acute fatty liver of pregnancy (if pregnant)
Biliary obstruction
- Choledocholithiasis
- Cholangitis
- Pancreatic head mass
Other Considerations
- Alcoholic hepatitis (if significant alcohol history)
- Non-alcoholic steatohepatitis (NASH) flare
- Acute hepatitis from other viruses: EBV, CMV (especially if recent viral prodrome) 5, 8
- Hemolysis (elevated indirect bilirubin, but transaminases typically normal)
Investigations
Immediate Laboratory Tests (Stat)
Serological Testing for Viral Hepatitis 6:
- Hepatitis A: IgM anti-HAV (confirms acute infection)
- Hepatitis B:
- HBsAg (surface antigen)
- IgM anti-HBc (IgM antibody to core antigen - confirms acute HBV)
- Anti-HBs (indicates immunity/recovery)
- Hepatitis C:
- Anti-HCV antibody
- HCV RNA (if antibody positive or high suspicion)
- Hepatitis E: IgM anti-HEV (especially if recent travel or pregnancy)
- HIV testing (all cases) 6
- EBV and CMV serology (if acute/icteric presentation) 6
Liver Function Tests:
- AST/ALT: typically markedly elevated (>1000-3000 IU/L in acute viral hepatitis) 1
- ALT usually > AST in viral hepatitis
- AST:ALT ratio >2 suggests alcoholic hepatitis
- Alkaline phosphatase: mildly elevated (mean 269 U/L) 1
- Total and direct bilirubin: elevated (mean 5 mg/dL, range 3-8 mg/dL) 9, 1
- Albumin: usually normal in acute hepatitis (decreased suggests chronic disease)
Coagulation Studies (Critical for Prognosis):
- PT/INR: most important prognostic marker 2
- Factor V level: best monitor for progression to fulminant failure 2
Complete Blood Count:
- Hemoglobin (check for hemolysis)
- WBC (leukopenia common in viral hepatitis)
- Platelets (thrombocytopenia suggests cirrhosis or severe disease)
Comprehensive Metabolic Panel:
- Creatinine (renal function)
- Glucose (hypoglycemia suggests severe hepatic dysfunction)
- Electrolytes
Additional Tests:
- Autoimmune markers (if viral serology negative or atypical features) 6:
- ANA (antinuclear antibody)
- ASMA (anti-smooth muscle antibody)
- Immunoglobulin levels (IgG typically elevated in AIH)
- Ceruloplasmin and 24-hour urine copper (if age <40 years, to exclude Wilson's disease) 5
- Pregnancy test (if female of childbearing age)
- Toxicology screen (if history unclear)
- Acetaminophen level (if any possibility of overdose)
Imaging
Right Upper Quadrant Ultrasound (within 24 hours) 6:
- Exclude biliary obstruction (dilated bile ducts, stones)
- Assess liver echotexture
- Evaluate for ascites
- Doppler to assess hepatic vasculature (exclude Budd-Chiari)
CT or MRCP: if ultrasound suggests biliary obstruction or if diagnosis unclear
Liver Biopsy
Indications 6:
- Diagnosis remains uncertain after non-invasive workup
- Suspected autoimmune hepatitis (required for diagnosis)
- Atypical presentation
- Contraindications: INR >1.5, platelets <50,000, ascites (use transjugular approach if needed)
Management
Risk Stratification
Low Risk (Outpatient Management Acceptable):
- Alert and oriented
- Tolerating oral intake
- INR <1.5
- Bilirubin <10 mg/dL
- No encephalopathy
- Reliable for follow-up
High Risk (Hospitalization Required):
- INR ≥1.5 (acute severe hepatitis) 6
- Any encephalopathy (acute liver failure - urgent transplant center referral) 6
- Intractable vomiting/unable to maintain hydration
- Bilirubin >15 mg/dL
- Age >40 years with jaundice >7 days before presentation 2
- Hypoglycemia
- Renal dysfunction
- Suspected drug-induced liver injury (requires drug withdrawal and monitoring)
Supportive Care
Outpatient Management:
- Rest: as tolerated, no strict bed rest required
- Nutrition:
- Small, frequent meals (anorexia improves with jaundice onset)
- Adequate caloric intake
- No specific dietary restrictions
- Avoid alcohol completely
- Hydration: maintain oral fluid intake
- Medications:
- Stop all non-essential medications 6
- Avoid hepatotoxic drugs
- Acetaminophen: avoid or use minimal doses (<2g/day)
- Activity: gradual return as symptoms improve
Inpatient Management:
- IV hydration if unable to tolerate oral intake
- Monitor mental status every 4-8 hours (watch for encephalopathy)
- Serial laboratory monitoring:
- Daily: INR, bilirubin, AST/ALT, creatinine
- Twice daily if INR rising or mental status changes
- Nutritional support: enteral nutrition if prolonged anorexia
- Avoid sedatives (can precipitate encephalopathy)
Specific Antiviral Therapy
Hepatitis A:
- No antiviral therapy available
- Supportive care only
- Complete recovery expected in >95% within 6 months 1
- Mortality 0.3% overall, 1.8% if age >49 years 10
Hepatitis B (Acute):
- Antiviral therapy rarely needed (95% of adults clear spontaneously) 11
- Consider treatment only if:
- Severe acute hepatitis (INR >1.5, bilirubin >10 mg/dL)
- Protracted course (>4 weeks of symptoms)
- Acute liver failure
- If treated: entecavir or tenofovir
Hepatitis C (Acute):
- Immediate treatment recommended at diagnosis 11
- Only 25% clear spontaneously 11
- Direct-acting antivirals (DAAs): 8-12 week course
- Curative in >95% 11
Hepatitis E:
- Usually self-limited
- Supportive care
- High mortality in pregnant women (up to 20%)
Acute Liver Failure Management
If encephalopathy develops (any grade) 6:
- Immediate transfer to liver transplant center
- ICU admission
- Lactulose: 30 mL PO/NG q2-4h (target 2-3 soft stools/day)
- Rifaximin: 550 mg PO BID
- Monitor for complications:
- Cerebral edema (consider ICP monitoring if Grade 3-4 encephalopathy)
- Coagulopathy (give FFP/platelets only if active bleeding or before procedures)
- Renal failure (may require CRRT)
- Hypoglycemia (frequent glucose checks, IV dextrose)
- Infection (low threshold for antibiotics)
- List for urgent liver transplantation
- Survival with medical management alone: 9-32% in AIH-ALF 6
- Transplant offers best survival
Monitoring and Follow-up
Outpatient Follow-up Schedule:
- Week 1: Repeat INR, bilirubin, AST/ALT
- If INR rising or symptoms worsening → hospitalize
- Week 2-4: Weekly labs until improving trend
- Month 2-3: Every 2-4 weeks until normalization
- Month 6: Confirm complete biochemical recovery 1
Indications for Urgent Re-evaluation:
- Confusion or drowsiness
- Persistent vomiting
- Bleeding (any site)
- Worsening jaundice
- Abdominal distension
Prevention and Counseling
Hepatitis A:
- Vaccination of close contacts and household members 12
- Immune globulin (IG) for unvaccinated contacts within 2 weeks of exposure 12
- Hand hygiene education
Hepatitis B:
- Vaccination of household and sexual contacts 12
- Hepatitis B immune globulin (HBIG) for unvaccinated contacts
- Safe sex practices
- No sharing of razors, toothbrushes
Hepatitis C:
- No vaccine available
- Counsel on transmission risks (blood exposure, injection drug use)
- Safe sex practices (barrier protection with multiple partners) 9
General:
- Avoid alcohol completely (accelerates fibrosis progression) 4
- No blood/organ donation 9
- Report to public health authorities (required for hepatitis A, B, C)
Prognosis
Hepatitis A:
- Complete recovery in >95% within 6 months 1
- Fulminant hepatic failure: 0.14-0.35% of hospitalized cases 2
- No chronic infection
Hepatitis B (Acute):
- 95% of immunocompetent adults recover completely 11
- 5% progress to chronic infection
- Fulminant hepatic failure: <1%
Hepatitis C (Acute):
- 25% spontaneous clearance 11
- 75% progress to chronic infection without treatment
- With immediate DAA therapy: >95% cure 11
Hepatitis E:
- Usually self-limited
- Mortality 1-2% overall
- 20% mortality in pregnant women
Common Pitfalls to Avoid
Assuming viral etiology without serological confirmation - always test for hepatitis A, B, C, E, and consider drug-induced liver injury 7
Missing autoimmune hepatitis - 40% present as "acute hepatitis" and require immunosuppression, not just supportive care 5
Delaying transplant referral - any encephalopathy = acute liver failure requiring immediate transplant center transfer 6
Not monitoring INR closely - INR is the best predictor of progression to fulminant failure 2
Incomplete drug history - always ask about herbal supplements, over-the-counter medications, and drugs started within 12 months 6
Missing Wilson's disease in patients <40 years - always check ceruloplasmin 5
Not testing for HIV - recommended in all cases of viral hepatitis 6
Giving corticosteroids empirically - can worsen viral hepatitis; only appropriate for confirmed autoimmune hepatitis after viral causes excluded 6